IPOs This Week: 5/14/18
IPOs This Week: 5/14/18.....»»
Week In Review: Human Gene Editing Scandal Revisited; Can China Biopharma Continue To Expand? News On 3 China Life Science IPOs
Week In Review: Human Gene Editing Scandal Revisited; Can China Biopharma Continue To Expand? News On 3 China Life Science IPOs.....»»
The Funded: Mixed results from Bay Area"s non-Uber IPOs this week
While Uber Technologies Inc.'s historic-sized IPO hogged the spotlight, two much smaller Bay Area offerings went public with mixed success on Thursday and Friday. Shares of South San Francisco-based Cortexyme Inc. (NASDAQ:CRTX) finished their first .....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»
Are the Pinterest and Zoom IPOs Cooling Off?
Pinterest and Zoom Video Communications captured the attention of many investors when they came public last week. Each company saw explosive gains out of the gate on Thursday, but let’s check in on........»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
Tech Stocks This Week: 2 Soaring IPOs and Apple"s Settlement With Qualcomm
Find out why Zoom and Pinterest soared and how Apple and Qualcomm finally came to terms......»»
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter
U.S. IPO Week Ahead: No IPOs But These 12 Deals Can Hop Back In After Easter.....»»
U.S. IPO Weekly Recap: All IPOs Up Or Flat In An 8-IPO Week Led By Pinterest And Zoom
U.S. IPO Weekly Recap: All IPOs Up Or Flat In An 8-IPO Week Led By Pinterest And Zoom.....»»
US IPO Weekly Recap: All IPOs up or flat in an 8-IPO week led by Pinterest and Zoom
Despite losing .....»»
Cramer"s game plan: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnings and stock trading......»»
Cramer: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnuings and stock trading......»»
Dow, S&P 500 open in record territory as investors watch for Pinterest, Zoom IPOs
U.S. stocks opened modestly higher Thursday morning as investors weighed a stream of data and economic reports, in the final day of trading this week. (Markets will be closed in observance of Good Friday). The Dow Jones Industrial Average rose .....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs
U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs.....»»
US IPO Week Ahead: Pinterest and Zoom headline year"s busiest week with 8 IPOs
A whopping eight IPOs plan.....»»
Succinct Summation of Week’s Events 4.12.19
Succinct Summations for the week ending April 11th, 2019 Positives: 1. Markets continued to act better in light of IPOs, Disney streaming news 2. Jobless claims fell 8k w/o/w, f.....»»
U.S. IPO Weekly Recap: Growth IPOs Take The Lead In A 5-IPO Week
U.S. IPO Weekly Recap: Growth IPOs Take The Lead In A 5-IPO Week.....»»
The Week In Cannabis: SAFE Banking Act, Stocks In Red, IPOs, High Tech Agro Projects And Celebs In Marijuana
It was a big week for can.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Biotech stocks came under pressure last week despite two FDA approvals coming through. read more.....»»